Fertility Inc.: The Embryo Editing Dinner

The episode explores the ethical and societal implications of embryo editing and screening technologies. It begins with an "Embryo Editing Dinner" hosted by Coinbase CEO Brian Armstrong, highlighting Silicon Valley's interest in genetically engineering babies. The discussion covers the potential risks of embryo editing, including unintended genetic consequences and the possibility of "designer babies" and eugenics. The episode also investigates Preventive, a company backed by Armstrong and OpenAI CEO Sam Altman, which aims to use gene editing to correct genetic conditions, and touches on the legal and ethical concerns surrounding their work in the U.S. and abroad. Finally, the conversation shifts to embryo screening, a legal alternative, and companies like Orchid and Nucleus that offer trait selection, raising further questions about the morality of choosing desirable traits in offspring.